Zimmer appointed Michael J. Farrell to its board of directors.
Mr. Farrell currently serves as CEO of ResMed, which is focused on the development and distribution of medical products for the diagnosis and management of respiratory disorders. He previously served as President-Americas of ResMed. He has also worked in management consulting and biotechnology.
More articles on devices:
10 key facts on the global trauma fixation market
Orthopedic companies named among worst 3 medical device stocks
12 key observations on orthopedic device company stock — Zimmer, Medtronic & Stryker